Correlation of international prostatic symptom score with prostate volume

Correlation of international prostatic symptom score with prostate volume

Objective: To evaluate the correlation of International Prostatic Symptom Score with Prostate Volume of Benign Prostatic Hyperplasia patients. Study Design: A Cross- out sectional study was done. Qualitative variables measured by Chi square test and quantitative by ANOVA. Pearson correlation &...

Full description

Saved in:

Bibliographic Details
Main Authors:	Iffat Raza, Maria Mohiuddin, Syeda Bushra Ahmed, Mubina Lakhani, Sahrish Mukhtar, Nuzhat Hassan
Format:	Article
Language:	English
Published:	Rawalpindi Medical University 2023-01-01
Series:	Journal of Rawalpindi Medical College
Online Access:	https://www.journalrmc.com/index.php/JRMC/article/view/1900
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correlation of Uroflowmetry with Prostate Volume and International Prostatic Symptom Score (IPSS)
by: Iffat Raza, et al.
Published: (2022-10-01)

Frequency of branching pattern variation of the renal artery in a subset of Karachi population: A Study on Multi-Detector Computed Tomography
by: Maria Mohiuddin, et al.
Published: (2024-06-01)

Usefulness of the frequency-volume chart over the International Prostate Symptom Score in patients with benign prostatic hyperplasia in view of global polyuria.
by: Sangjun Yoo, et al.
Published: (2018-01-01)

The “prostate-pelvic syndrome” theory used in patients with type-III prostatitis and its correlation with prostate volume
by: Xiao-Ma Zhang, et al.
Published: (2025-01-01)

Changes in prostate volume during prostate SBRT delivered on an MR-Linac and correlation with acute toxicity
by: Jason Gurewitz, et al.
Published: (2025-09-01)

Accuracy of a "Single Question Nocturia Score" compared to the "International Prostate Symptoms Score" in the evaluation of lower urinary tract symptoms in benign prostatic hyperplasia: A study performed at Ndola Teaching Hospital, Ndola, Zambia.
by: Teddy Kajimotu, et al.
Published: (2018-01-01)

Correlation of expression of Cyclin D1 and E-cadherin with gleason grade, serum prostate specific antigen levels and prostatic volume in prostatic carcinoma
by: C Aatirah, et al.
Published: (2023-07-01)

Olfactory Fossa Depth Assessment Based on Keros Classification using Computed Tomography
by: Mubina Lakhani, et al.
Published: (2017-06-01)

The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature
by: Dominique Thomas, et al.
Published: (2019-10-01)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
by: Eric Margolis, et al.
Published: (2025-03-01)

CORRELATION OF STORAGE SYMPTOMS OR OVERACTIVE BLADDER SYMPTOMS POST TRANSURETHRAL RESECTION OF THE PROSTATE WITH THE DURATION OF CATHETER USE IN A PATIENT WITH URINARY RETENTION DUE TO BENIGN PROSTATE HYPERPLASIA
by: Alfindy Perdinan, et al.
Published: (2025-05-01)

P10 Which parameters indicate clinically significant prostate cancer in different prostate volumes?
by: I. Hacibey, et al.
Published: (2025-07-01)

Prostate cancer detection with transrectal in-bore MRI biopsies: impact of prostate volume and lesion features
by: Alexander Schaudinn, et al.
Published: (2025-03-01)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2021-07-01)

Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care
by: Harma Johanna Alma, et al.
Published: (2019-12-01)

Prostate volume, LUTS scale, and uroflowmetry of benign prostate hyperplasia patients with type 2 diabetes mellitus
by: A. N. Hakim, et al.
Published: (2024-11-01)

Diagnostic Utility Of Various Biomarkers For Prostate Cancer: A Review
by: Beenish Hussain Nomani, et al.
Published: (2019-06-01)

Lesional volume in the prediction of clinically significant prostate cancer
by: Bellamy Brodie, et al.
Published: (2025-07-01)

Analytical Validation of MyProstateScore 2.0
by: Jacob I. Meyers, et al.
Published: (2025-04-01)

Association between magnesium depletion score and prostate cancer
by: Hongyang Gong, et al.
Published: (2025-02-01)

Multicenter comparative analysis of preoperative and postoperative outcomes after holmium laser enucleation of the prostate based on the prostate volume
by: Samer Al-Rawashdah, et al.
Published: (2025-05-01)

Correlation of Intravesical Prostatic Protrusion with Severity of Lower Urinary Tract Symptoms in Men With Symptomatic Benign Prostatic Hyperplasia at University of Nigeria Teaching Hospital, Ituku-Ozalla Enugu
by: Chukwunonso Anthony Iwenofu, et al.
Published: (2024-10-01)

Heterogeneity symptoms of urgency in patients with benign prostatic hyperplasia
by: V. L. Medvedev, et al.
Published: (2021-06-01)

Heterogeneity symptoms of urgency in patients with benign prostatic hyperplasia
by: V. L. Medvedev, et al.
Published: (2021-06-01)

Severe Xanthogranulomatous prostatitis mimicking prostate cancer: a case report
by: Wael Abdo Hassan, et al.
Published: (2024-12-01)

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?
by: Cheng-Ling Lee, et al.
Published: (2023-01-01)

Outcomes of Prostatic Artery Embolization for Treating Benign Prostatic Hyperplasia Symptoms: A Prospective Single‐Center Study
by: Sina Delazar, et al.
Published: (2025-03-01)

Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
by: Matteo Pacini, et al.
Published: (2025-02-01)

Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml)
by: Xiao Xiao, et al.
Published: (2024-12-01)

Economic analysis of the use of holmium enucleation of the prostate and laparoscopic simple prostatectomy in the surgical treatment of large-volume prostatic hyperplasia
by: S. N. Volkov, et al.
Published: (2024-07-01)

Impact of pharmacologic therapy for benign prostatic hyperplasia on prostate volume and free testosterone and consequently on urinary parameters and sexual desire in men
by: Stojanović Nebojša, et al.
Published: (2017-01-01)

Use of a BMI-independent biomarker-based prostate cancer risk score to identify and triage individuals at risk of prostate disease
by: Joanne Watt, et al.
Published: (2025-07-01)

Detection of prostate cancer in the PSA gray zone using prostate-specific antigen mass ratio combined with PI-RADS score
by: Weilin Li, et al.
Published: (2025-07-01)

Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus
by: Shahana Sarwar, et al.
Published: (2017-01-01)

Prostatic artery embolization in treatment of benign prostatic hyperplasia: outcome and efficacy in medium-sized compared to large prostates
by: Noha Elghitany, et al.
Published: (2025-06-01)

Consistency of ultrasonography and magnetic resonance imaging in measuring prostate size and volume
by: MAO Xiaoli, et al.
Published: (2024-05-01)

Body mass index and benign prostatic hyperplasia correlate with urinary microbiome diversity and lower urinary tract symptoms in men
by: Kate R. Bowie, et al.
Published: (2025-05-01)

IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
by: V. B. Filimonov, et al.
Published: (2019-06-01)

Analysis of urinary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospective study
by: Yoshiyuki Miyazawa, et al.
Published: (2024-11-01)

Comment on “The factors impacting on gleason score upgrading in prostate cancer with initial low gleason scores”
by: Rui-Jun Wang, et al.
Published: (2025-07-01)